Vanguard Information Technology ETF (VGT) — ()
Key Metrics
News
Madden to Halftime: ETFs Behind Super Bowl LX
Published: by:
Sentiment: Neutral ()
Months before Super Bowl LX kicks off at Levi's Stadium on February 9, the game was already being played, predicted, and celebrated across screens worldwide through companies held in the …
Read More
VGT: A Glorious Vanguard Big-Tech ETF For The American AI Trade
Published: by:
Sentiment: Positive ()
The Vanguard Information Technology ETF (VGT) is a cost-efficient, high-performing vehicle for diversified big-tech exposure to the American AI trade. It has an average annual 10-year return of 22.6%. VGT …
Read More
3 Tech ETFs To Load Up on Before 2026
Published: by:
Sentiment: Positive ()
As we come to the close of 2025, tech stocks are gaining pace, and they've remained one of the best performing in the industry.
Read More
Is VGT or FTEC the Better Tech ETF? Here's How They Compare on Risk, Returns, and Fees
Published: by:
Sentiment: Neutral ()
VGT holds a much larger asset base and slightly more holdings than FTEC, but both funds track the same sector with near-identical allocations. FTEC comes in with a marginally lower …
Read More
VGT vs. SOXX: How Does Broad Tech Diversification Compare to Semiconductor Exposure for Investors?
Published: by:
Sentiment: Positive ()
VGT charges a much lower expense ratio and holds over 10 times as many stocks as SOXX. SOXX delivered a stronger one-year return but experienced a steeper five-year drawdown than …
Read More
VGT: An Efficient ETF To Capture The Growth Of AI
Published: by:
Sentiment: Positive ()
Vanguard Information Technology ETF (VGT) offers focused exposure to the AI-driven tech sector, outperforming SPY and QQQ YTD with an 18% total return. VGT's top ten holdings comprise over 59% …
Read More
The 3 Vanguard ETFs I'm Most Excited About for 2026 And Beyond
Published: by:
Sentiment: Positive ()
In terms of top exchange traded fund (ETF) providers I think investors should consider, Vanguard remains a top pick of mine.
Read More
Is the Vanguard Information Technology ETF (VGT) the Smartest Investment to Buy With $1,000 Right Now?
Published: by:
Sentiment: Positive ()
Investing in an industry-specific ETF can make it easier to gain exposure to the tech sector without choosing individual stocks. Compared to some other investments, this particular ETF helps balance …
Read More
VGT: The Technology Sector's Uptrend Is Likely To Continue Despite Trade War Concerns
Published: by:
Sentiment: Positive ()
Vanguard Information Technology Index Fund ETF Shares (VGT) earns a buy rating due to strong earnings growth and robust US economic outlook. The US stock market's uptrend is fueled by …
Read More
2 Vanguard ETFs To Load Up On in October
Published: by:
Sentiment: Neutral ()
October doesn't have to be a scary month if you're properly positioned with exchange traded funds (ETFs).
Read More
Hold XLK, Buy VGT: How To Stay In Tech Without Being Dependent On 3 Ticker Symbols
Published: by:
Sentiment: Positive ()
Vanguard Information Technology Index Fund ETF Shares, VGT, offers broader tech exposure and less concentration risk than The Technology Select Sector SPDR® Fund ETF, XLK. VGT includes 300 stocks, providing …
Read More
How Active Tech ETF GTEK Has Outperformed VGT YTD
Published: by:
Sentiment: Positive ()
Active ETFs have become a key part of the investing landscape for retail investors and institutional investors, alike.
Read More
5 Vanguard ETFs to Buy With $500 and Hold Forever
Published: by:
Sentiment: Neutral ()
With the stock market sitting near record highs, many investors may be tempted to wait for a pullback before buying any new shares. The problem is that waiting for a …
Read More
3 ETFs Smart Retirees Have in Their Portfolios
Published: by:
Sentiment: Neutral ()
If you're a retiree or if you're planning to be one, it's very worthwhile to have exchange-traded funds (ETFs) in your portfolio.
Read More
Top Tech ETFs Poised for Explosive Growth
Published: by:
Sentiment: Positive ()
The earnings season and the momentum in the economy have led the tech sector higher again, driven by strong industry players like Microsoft ( NASDAQ:MSFT ) and NVIDIA ( NASDAQ:NVDA …
Read More
VGT: Can't Be Rattled, Surprising Value, Buy And Don't Look Back
Published: by:
Sentiment: Positive ()
I upgrade VGT to a long-term buy due to its strong fundamentals, robust earnings, and leadership in tech innovation. VGT offers broad, pure tech exposure with low expenses and diversification …
Read More
1 Tech ETF to Load Up On, and 1 to Avoid Right Now
Published: by:
Sentiment: Negative ()
The tech sector has had a roller coaster of a year. The tech-heavy Nasdaq Composite , one of the U.S. stock market's three main indexes, lost 20% of its value …
Read More
Is This Vanguard ETF's Rally Too Good to Last? Why This Tech Fund Could Crash
Published: by:
Sentiment: Neutral ()
Key Points in This Article: Vanguard Information Technology ETF‘s (VGT) 22.6% annualized return over the past decade outpaces the S&P 500, but its 43% weighting in just three stocks heightens …
Read More
Tariff-Led Volatility Ahead for Big Tech? ETFs in Focus
Published: by:
Sentiment: Negative ()
Tariff tensions loom, but tech ETFs like XLK, CIBR, CLOU and SMH could benefit from AI growth and cybersecurity demand.
Read More
5 Sector ETFs Set to Power Q2 Earnings Growth
Published: by:
Sentiment: Positive ()
XLY, ITA, VGT, XLF and XLU are positioned to benefit as Q2 earnings growth takes off across key S&P 500 sectors.
Read More
Tech ETFs Hit New Highs as NVIDIA Powers Market Rally
Published: by:
Sentiment: Positive ()
NVIDIA's $4T milestone sparks a tech rally, sending major ETFs like XLK, VGT and SMH to fresh all-time highs.
Read More
4 Growth ETFs With Double-Digit Upside Potential in 2025
Published: by:
Sentiment: Positive ()
Growth stocks and ETFs had a rough start in 2025, but with headwinds giving way to tailwinds, the second half of the year can be a good one for investors.
Read More
Big ETF Inflows of Last Week: QQQ, IBIT & More
Published: by:
Sentiment: Positive ()
QQQ and IBIT led last week's $17B ETF inflows, as investors piled into tech, Bitcoin, and gold amid market resilience.
Read More
Vergent Bioscience Presents Phase 2B VISUALIZE Results Demonstrating Abenacianine for Injection (VGT-309) with Intraoperative Molecular Imaging Improved Tumor Visualization During Lung Surgery
Published: by:
Sentiment: Neutral ()
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor targeted imaging agents, announced new data being presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. These results …
Read More
VGT: I Want More Diversification
Published: by:
Sentiment: Positive ()
VGT's extreme concentration in its top three holdings undermines the diversification benefit I expect from an ETF. Current tech sector valuations are historically high, leaving little room for further multiple …
Read More
The Nasdaq Just Soared 30% From Its 2025 Low: 3 Vanguard ETFs to Buy Now
Published: by:
Sentiment: Positive ()
The Nasdaq Composite (^IXIC 0.52%) closed Wednesday at 19,146.81 -- a staggering 29.5% rally from its 52-week intraday low of 14,784.03 on April 7.
Read More
Select Live Vanguard IT ETF (VGT): Tech Stocks Buoy Market Sentiment Amid Renewed Economic Optimism
Published: by:
Sentiment: Positive ()
The markets are extending their gains in this midweek session. Technology stocks are buoying wider market sentiment.
Read More
Live Vanguard IT ETF (VGT): Markets Return to Volatile Ways Despite China Trade Progress
Published: by:
Sentiment: Positive ()
The markets came out of the gate higher across the board but those gains have evaporated.
Read More
Live Vanguard IT ETF (VGT): Tech Stocks Rise on Trade Deal Tailwinds
Published: by:
Sentiment: Positive ()
Tech stocks are joining in on today's market gains on positive trade developments between the U.S.
Read More
Vergent Bioscience to Present Data on Abenacianine for Injection (VGT-309) at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: by:
Sentiment: Neutral ()
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that an abstract on abenacianine for injection (VGT-309) will be featured at the 2025 American Society of Clinical …
Read More